The expression of CD56 on malignant plasmocytes and bone disease in patients with multiple myeloma

被引：0
|
作者：
Buchler, Tomas [1 ]
Dolezelova, Eva [1 ]
Fabian, Pavel [2 ]
Pour, Ludek [1 ]
Moulis, Mojmir [3 ]
Kren, Leos [3 ]
Adam, Zdenek [1 ]
Krejci, Marta [1 ]
机构：
[1] Masaryk Univ Hosp, Dept Internal Med, Brno, Czech Republic
[2] Masaryk Mem Canc Inst, Dept Pathol, Brno, Czech Republic
[3] Masaryk Univ Hosp, Inst Pathol Anat, Brno, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：163 / 163
页数：1
相关论文
共 50 条
  • [31] CD56 EXPRESSION AND TREATMENT OUTCOME WITH BORTEZOMIB THERAPY IN PATIENTS WITH RELAPSED PLASMA CELL MYELOMA
    Ahmed, O.
    Lentaigne, C.
    Wright, F.
    McAleese, D.
    Dangwa, F.
    Wechalekar, A.
    Hughes, D.
    Mehta, A.
    McNamara, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 582 - 583
  • [32] The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
    C Pellat-Deceunynck
    S Barillé
    G Jego
    D Puthier
    N Robillard
    D Pineau
    M-J Rapp
    J-L Harousseau
    M Amiot
    R Bataille
    Leukemia, 1998, 12 : 1977 - 1982
  • [33] The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
    Pellat-Deceunynck, C
    Barillé, S
    Jego, G
    Puthier, D
    Robillard, N
    Pineau, D
    Rapp, MJ
    Harousseau, JL
    Amiot, M
    Bataille, R
    LEUKEMIA, 1998, 12 (12) : 1977 - 1982
  • [34] The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system
    Chang, H
    Bartlett, ES
    Patterson, B
    Chen, CI
    Yi, QL
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (04) : 539 - 541
  • [35] CD56 expression of mycloid neoplasms
    Sakai, N
    Saito, Y
    Uzuka, Y
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 185 - 188
  • [36] Expression of CD56 in patients with adenomyosis and its correlation with dysmenorrhea
    Wang, Fei
    Shi, Xixi
    Qin, Xiaoyan
    Wen, ZeQing
    Zhao, Xingbo
    Li, Changzhong
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 194 : 101 - 105
  • [37] Dexamethasone downregulates CD38 and CD56 on bone marrow plasma cells in myeloma.
    Haznedar, R
    Topal, G
    BLOOD, 1995, 86 (10) : 3324 - 3324
  • [38] Intercorrelation of Expression of CD56, CD117, CD33, CD20 Antigens with Survival Rates in Patients with Multiple Myeloma in Gomel Region in Belarus
    Kozich, Z.
    Martinkov, V.
    Pugacheva, Z.
    Smimova, L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S19 - S19
  • [39] Prognostic significance of surface markers expressed in multiple myeloma: CD56 and other antigens
    Sahara, N
    Takeshita, A
    LEUKEMIA & LYMPHOMA, 2004, 45 (01) : 61 - 65
  • [40] The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era
    Okura, Miyuki
    Ida, Naoko
    Yamauchi, Takahiro
    MEDICAL ONCOLOGY, 2020, 37 (11)
12345